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modulate the human gut microbiota and protect against unwanted antibiotic side 
effects. A. Koutsos, L. Conterno, M. Lima, F. Fava, R. Viola, and K. Tuohy, Department of 
Food Quality and Nutrition, Fondazione Edmund Mach, IASMA Research and Innovation 
Centre, Via E. Mach 1, 38010 S. Michele (TN), Italy 
 
Introduction 
 
The gut microbiota, comprising many thousands of microorganisms, constitutes an important 
barrier to ingested pathogens, affects the development and function of the immune system 
and contributes to the co-metabolic processes with the host, most notably the enterohepatic 
circulation of bile acids and co-metabolism of complex plant polysaccharides and 
polyphenols. However, antibiotics can disrupt these beneficial activities. Although they 
remain our first line therapy against bacterial pathogens and an essential weapon in modern 
medicines fight against infectious disease, antibiotics can have side effects (1). A proportion 
of orally ingested antibiotics may escape absorption in the stomach and upper gut, and 
inadvertently reach non-target intestinal sites such as the colon, home to the vast majority of 
the human gut microbiota. Diarrhoea is a common side effect of many oral antibiotic 
therapies and in its most extreme, can lead to Clostridium difficile associated diarrhoea 
(CDAD). Clostridium difficile is a spore-forming biofilm generating bacterial pathogen 
naturally more resistant to antibiotics than other gut bacteria is now recognised as a “super-
pathogen” responsible for many nosocomial infections in modern hospitals. In this small in 
vitro experiment, we investigated the ability of different functional food approaches to first of 
all to fortify the human gut microbiota and secondly, to protect the gut microbiota from the 
unwanted side effects of residual broad spectrum antibiotic.  
 
Material and Methods 
 
Anaerobic batch cultures (pH 6.8, 37
 
ºC) were used to evaluate the microbiota modulatory 
abilities of abilities of different treatment regimes: (i) prebiotic (inulin 1% w/v), (ii) a herbal 
mix (0.1 % w/v, a mixture of propolis, olive and thyme extracts provided by Aboca Srl. 
Italy), (iii) inulin plus the herbal mix (prebiotic + herbal mix, 15 and 0.1% respectively), (iv) 
prebiotic plus antibiotic, and (viii) prebiotic plus herbal mix and antibiotic and (ix) untreated 
faecal inoculum (control). Antibiotic, augmentin (amoxicillin and clavulanic acid) was 
always added at 10% w/v per 200 ml reaction vessel of the commonly used daily dose, 
250mg/125mg. In-vitro fermentations were conducted in triplicate using faecal samples 
collected from three healthy, male subjects aged between 30 and 47, as described in Connolly 
et al. (2012) (2). A 5 ml sample from each vessel was taken immediately for analysis 
similarly samples were taken at 5, 10, 24 and 48 hours.   
The enumeration of microbial populations was carried out using fluorescently labelled 16S 
rRNA targeted oligo-nucleotide probes and fluorescent in situ hybridisation (FISH). 
Oligonucleotide probes; Bif164, specific for the Bifidobacterium genus; Lab158, for the 
Lactobacillus– Enterococcus group; Bac303, specific for the Bacteroides and Prevotella 
group; His150, for the Clostridium histolyticum subgroup; Erec482 for the Ruminococcus–
Eubacterium–Clostridium (EREC) cluster; FPrau for Faecalibacterium prausnitzii, Ent for 
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enterobacteria and Cdif Clostridium difficile, were chosen based on the high abundance of 
these bacteria as part of the whole bacterial populations of the colonic microbiota.  
 
Results and Discussion 
 
Total bacteria varied little over the course of the experiment regardless of treatment, 
prebiotic, antibiotic, herbal mix or mixed treatments. Numbers of bifidobacteria increased 
significantly over time up to 10h for the inulin fermentation and a similar level was observed 
after 24h in the inulin plus herbal mix fermentation. This may indicate that the herbal mix, 
while achieving the same level of bifidogenesis in the presence of inulin, did so at a slower 
rate, a trait which if translated to the human situation, might indicate extension of beneficial 
prebiotic activities into the distal colon where it may have added health promoting effects (3). 
In all cases, the presence of the antibiotic inhibited bifidogenesis and indeed reduced 
bifidobacterial numbers. This was particularly apparent in the inulin plus antibiotic 
fermentation, which at time 48h, gave a lower level than the herbal mix, inulin plus 
antibiotic.  
For Bacteroides spp., a statistically significant reduction in numbers was observed after 24h 
for the herbal mix, inulin and antibiotic fermentation. A similar reduction was observed in 
inulin plus antibiotic, but this was not statistically significant probably because of slightly 
lower starting levels of Bacteroides. Other fermentations showed reductions in Bacteroides 
populations at 24 or 48 hours, while small increases were found in the inulin, inulin plus 
antibiotic and herbal mix fermentation vessels at 10 h. Comparing the herbal mix with inulin 
in the presence or absence of antibiotic, the herbal mix plus inulin gave slightly lower 
numbers of Bacteroides through out the incubation period, which in the presence of the 
antibiotic, the herbal mix plus inulin appeared to protect Bacteroides numbers up until 10 h. 
However, these small changes did not appear to be statistically significant. Bacteroides, a 
dominant Gram negative genus within the human colon, includes both pathogenic and 
commensal species. Ley et al. (2006) (4) were the first to show that obese humans have a 
reduced Bacteroidetes to Firmicutes ratio. These data do not directly relate to numbers of 
Bacteroides enumerated by the FISH probe we have used here as they also include the 
Prevotella. De Filippo et al. (2010) (5) more recently, showed that people following a 
Western-style diet had much reduced relative abundance of Prevotella compared to 
populations following traditional, ancestral diets in Africa, rich in plant foods, fiber and 
polyphenols and low in fat, refined sugars and meat. 
No change or a small reduction in numbers of F. prausnitzii was observed in the inulin, 
faeces only, inulin plus antibiotic, and herbal mix with inulin plus antibiotic. A small, though 
not statistically significant, increase in F. prausnitzii was observed in the herbal mix plus 
inulin vessel, indicating that the herbal mix may have an added stimulatory effect on this 
important species within the gut microbiota in the presence of fermentable substrate. F. 
prausnitzii is an important butyrate producing bacterium, which has been suggested to play a 
protective role in inflammatory bowel disease (6).  
Statistically significant differences were observed in numbers of enterobacteria between the 
different fermentations after 48h of incubation. Generally, numbers did not change greatly for 
the negative control (faeces only) and inulin fermentations. The antibiotic treatment reduced 
numbers of enterobacteria regardless of treatment. Interestingly, the herbal mix plus inulin 
appeared to have a greater inhibitory effect against the enterobacteria than inulin alone.  
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Neither the antibiotic nor the functional food treatments appeared to have any impact on 
numbers of Lactobacillus/Enterococcus over the course of the fermentation study. A small 
decrease in numbers was observed in all fermentations after 10 hours, but this change was not 
significant compared to starting levels, apart from the fermenter dosed with inulin plus 
antibiotic, where the drop in lactobacilli/enterococci numbers was statistically significant at 
24 h. 
Small but not stastistically significant changes in numbers of Eubacterium rectale were 
observed in most vessels over the course of the experiment. Inulin and the herbal mix plus 
inulin tended to increase numbers up to 24h, while the antibiotic tended to give reduced 
numbers at 48h. There was a dip in numbers at 24h for the inulin plus antibiotic vessel which 
did not appear until 48h for the herbal mix plus inulin and antibiotic vessel.  
Numbers of Clostridium histolyticum/perfringens group remained fairly stable over the 
course of the experiment and did not appear to be effected by either the functional foods nor 
presence of the antibiotic. Numbers of Clostridium difficile decreased in all vessels over the 
course of the experiment. Small, statistically significant differences between treatments after 
5 hours were not evident at later time points, indicating that these effects were transient and 
may not necessarily be representative.  
In conclusion, the herbal mixture plus inulin significantly modulated the composition and 
activity of the human gut microbiota in a manner similar to inulin alone, but with some 
additional herbal mix features, which could indicate enhanced health effects. The mix plus 
inulin also induced small, though favourable changes within key bacterial groups in a slightly 
different manner than inulin, specifically slowing bifidogenesis induced by inulin, which in 
humans might extend prebiotic activity into the distal colon, slightly higher levels of the 
butyrate producing, anti-inflammatory microorganism Faecalibacterium pruasnitzii 
compared to inulin alone and apparent protection of Eubacterium rectale group against 
antibiotic compared to the inulin alone. There was also some suggestion from the data of an 
apparent increased anti-enterobacterial activity of the herbal mix plus inulin compared to 
inulin alone. However, many of these differences within the gut microbiota was of a similar 
magnitude as those seen within inulin and further investigations, particularly in animals or in 
 
Bacterial populations (log10 cells/ml batch culture fluid) in pH-controlled and stirred batch cultures at 0, 5, 10, 24 and 48 h at different treatments. 
  Bif  F.Prau   Bac  Enter  Lab  Erec  C.His  C.Dif  Total  
Treatment Time (h) Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Only faeces 0 7.8 0.3 8.2 0.1 8.2 0.3 7.4 0.7 8.0 0.3 8.4 0.3 8.6 0.3 6.9 0.1 9.0 0.2 
 5 8.0 0.8 8.1 0.2 8.3 0.3 7.5 0.4 7.9 0.0 8.2 0.3 8.6 0.3 6.9ab 0.1 8.8 0.2 
 10 7.8 0.2 8.0 0.1 8.3 0.5 7.3 0.1 8.0 0.1 8.2 0.1 8.5 0.2 6.9 0.4 8.8 0.2 
 24 7.8 0.3 7.8 0.3 7.8 0.0 7.5 0.2 7.6 0.4 8.1abc 0.2 8.6 0.1 6.5 0.8 8.8 0.1 
 48 7.7 0.3 7.9 0.4 7.5 0.2 7.3abc 0.2 7.7 0.4 8.2 0.2 8.5 0.2 6.3 0.5 8.8 0.4 
Inulin 0 7.9 0.2  8.2 0.1 7.8 0.2 7.3 0.7 8.1 0.4 8.3 0.2 8.6 0.2 6.9 0.1 9.1 0.2 
 5 8.8 0.4 8.1 0.3 7.7 0.2 7.4 0.2 7.9 0.1 8.3 0.2 8.6 0.3 6.9ab 0.2 8.8 0.3 
 10   9.0* 0.4 8.1 0.3 8.1 0.1 7.2 0.8 8.0 0.3 8.4 0.3 8.8 0.6 7.0 0.6 9.0 0.3 
 24 8.8 0.2 8.2 0.3 8.0 0.4 7.2 0.6 7.8 0.2   8.5c 0.3 8.7 0.6 7.3 0.9 9.0 0.2 
 48 8.5 0.6 8.2 0.4 7.9 0.4  7.5a 0.3 7.9 0.0 8.4 0.5 8.6 0.5 6.8 0.9 9.0 0.2 
Inulin, antibiotic  0 7.8 0.5 8.2 0.2 7.8 0.3 7.3 0.5 8.1 0.2 8.2 0.2 8.8 0.3 6.8 0.0 8.9 0.1 
 5 7.9 0.6 8.0 0.3 7.4 0.6 7.3 0.9 7.9 0.2 8.1 0.4 8.6 0.4   6.7ab 0.1 8.8 0.2 
 10 7.8 0.8 7.9 0.2 8.3 0.5 7.0 0.5 8.0 0.1 8.2 0.3 8.5 0.4 6.9 0.2 8.9 0.2 
 24 7.6 0.4 7.7 0.2 7.5 0.7 6.3 0.5   7.7* 0.1  7.8ab 0.3 8.2 0.4 6.6 0.4 8.6 0.2 
 48 7.3 0.8 7.5 0.4 7.3 0.4  6.6bc 0.1 7.9 0.2 8.0 0.3 8.1 0.4 6.5 0.4 8.4 0.3 
Herbal mix, inulin  0 7.9 0.5 8.2 0.1 7.8 0.3 7.4 0.7 8.0 0.2 8.2 0.1 8.9 0.2 6.9 0.1 9.0 0.2 
 5 8.1 0.8 7.9 0.3 7.4 0.3 7.4 0.6 7.9 0.0 8.2 0.3 8.6 0.3  6.4abc 0.1 8.7 0.3 
 10 8.6 0.7 8.2 0.4 8.0 0.1 7.2 0.9 8.0 0.2 8.4 0.4 8.7 0.5 6.8 0.6 9.0 0.4 
 24 8.9 0.5 8.5 0.3 7.7 0.1 6.7 0.4 7.7 0.2   8.4bc 0.2 8.5 0.1 6.5 0.2 8.8 0.4 
 48 8.0 1.0 8.3 0.2 7.6 0.4 6.9abc 0.5 7.6 0.1 8.3 0.5 8.4 0.3 6.3 0.3 9.0 0.4 
Herbal mix, inulin, antibiotic 0 8.2 0.1 8.1 0.0 8.1 0.3 7.7 0.2 8.0 0.2 8.3 0.2 8.8 0.3 6.7 0.4 8.5 0.2 
 5 8.6 0.7 7.9 0.3 8.2 0.3 7.7 0.3 8.0 0.1 8.2 0.3 8.5 0.3  6.1c 0.3 8.4 0.1 
 10 7.7 0.8 7.9 0.3 8.3 0.2 6.7 1.2 8.1 0.1 8.1 0.2 8.7 0.3 6.6 0.4 8.9 0.3 
 24 7.8 0.9 7.9 0.5   7.4* 0.3 6.7 0.6 7.6 0.2 8.2abc 0.2 8.4 0.3 6.6 0.5 8.5 0.1 
 48 7.5 0.5 7.6 0.5   7.4* 0.4   7.0abc 0.4 7.7 0.2 7.9 0.2 8.4 0.4 6.1 0.4 8.6 0.2 
Univariate analysis of variance was used to analyse the effects of Treatment and Time on the bacterial population. When statistical differences were found, data were further tested by the Tukey post hoc test. 
Mean value (*) was significantly different from that at 0 h: P<0.05. Mean value for the same Time point with unlike superscript letters was significantly different between the different treatments: P<0.05 
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human subjects are required to confirm the beneficial modulation of the gut microbiota 
observed for the herbal mix plus inulin. 
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